| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/05/1997 | CA1339210C Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| 08/05/1997 | CA1339208C Fusion proteins containing a hinge region for enhanced cleavage |
| 08/05/1997 | CA1339205C Oligonucleotide-polyamide conjugates |
| 08/05/1997 | CA1339204C Mucin core polypeptide, antibodies and probes |
| 08/05/1997 | CA1339201C Chimera monoclonal antibody and a production process thereof |
| 08/05/1997 | CA1339199C Magnetic protein conjugates, a process for the preparation thereof, and the use thereof |
| 08/05/1997 | CA1339198C Antibodies to the antigen campath-1 |
| 08/05/1997 | CA1339197C A tissue adhesive |
| 08/05/1997 | CA1339193C Human rhinovirus receptor protein that inhibits virus infectivity |
| 07/31/1997 | WO1997027334A1 Methods for identifying inhibitors of rna viruses |
| 07/31/1997 | WO1997027311A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 07/31/1997 | WO1997027301A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | WO1997027300A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
| 07/31/1997 | WO1997027299A1 Mammalian cx3c chemokine genes |
| 07/31/1997 | WO1997027297A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | WO1997027296A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | WO1997027286A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | WO1997027284A2 Human rad50 and septin-2 genes and methods of use |
| 07/31/1997 | WO1997027220A2 Substrates and inhibitors for cysteine protease ich-1 |
| 07/31/1997 | WO1997027219A1 Methods for purification and use of erythropoietin binding protein |
| 07/31/1997 | WO1997027218A1 Method for evaluating and affecting male fertility |
| 07/31/1997 | WO1997027217A1 Peptides and uses thereof for therapy of celiac diseases |
| 07/31/1997 | WO1997027216A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | WO1997027215A1 Nucleotide and amino acid sequences of t. pallidum rare outer membrane protein |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997026916A1 Obesity protein analog compounds and formulations thereof |
| 07/31/1997 | WO1997026915A1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 07/31/1997 | WO1997026914A1 Methods and compositions for passive immunotherapy |
| 07/31/1997 | WO1997026913A1 A POLYPEPTIDE FROM LUNG EXTRACT WHICH BINDS AMYLOID-β PEPTIDE |
| 07/31/1997 | WO1997026912A2 Anti-cd18 antibodies for use against stroke |
| 07/31/1997 | WO1997026909A1 Highly concentrated, lyophilized, and liquid factor ix formulations |
| 07/31/1997 | WO1997026908A1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 07/31/1997 | WO1997026907A1 Novel administration of thrombopoietin |
| 07/31/1997 | WO1997026906A1 Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
| 07/31/1997 | WO1997026905A1 A synthetic macromolecular channel assembly for transport of chloride ions through epithelium |
| 07/31/1997 | WO1997026901A1 Regeneration of nerves in the central nervous system |
| 07/31/1997 | WO1997026883A1 Modulation of th1/th2 cytokine expression by ribavirin® and ribavirin® analogs in activated t-lymphocytes |
| 07/31/1997 | WO1997026882A1 Nucleoside analogs in combination therapy of herpes simplex infections |
| 07/31/1997 | WO1997026869A1 Novel 'burst-free' sustained release poly-(lactide/glycolide) microspheres |
| 07/31/1997 | WO1997026863A1 Process for the production of powdered pulmonary surfactant preparations |
| 07/31/1997 | WO1997026862A2 Improved concentrated injection and infusion solutions for intravenous administration |
| 07/31/1997 | WO1997026861A1 Medicament forms constituted in situ for releasing enzymes into wounds |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | WO1997026790A1 APOPTOSIS INDUCED BY SHIGELLA IpaB |
| 07/31/1997 | WO1997022360A3 Control of protein synthesis, and screening method for agents |
| 07/31/1997 | WO1997015269A3 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 07/31/1997 | WO1996040772A3 Agonist peptide dimers |
| 07/31/1997 | DE19604231A1 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen A pharmaceutical combination preparation, and its use for the treatment of gynecological disorders |
| 07/31/1997 | DE19602863A1 Agent for treating cancer and other diseases involving hyper-proliferation of cells |
| 07/31/1997 | DE19602332A1 Production of lung surfactant preparation in powder form |
| 07/31/1997 | DE19545351C1 Eukaryotische Zellen mit Hybridrezeptor und dadurch steuerbarem Genkonstrukt, Verfahren zu deren Herstellung und Verwendung dieser Zellen in der Gentherapie Eukaryotic cells with hybrid receptor and thereby controllable gene construct, to processes for their preparation and use of these cells for gene therapy |
| 07/31/1997 | CA2244900A1 Regeneration of nerves in the central nervous system |
| 07/31/1997 | CA2244693A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | CA2244412A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2244372A1 Methods for identifying inhibitors of rna viruses |
| 07/31/1997 | CA2244147A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | CA2243825A1 Obesity protein analog compounds and formulations thereof |
| 07/31/1997 | CA2243557A1 Methods and compositions for passive immunotherapy |
| 07/31/1997 | CA2243528A1 Medicament forms constituted in situ for releasing enzymes into wounds |
| 07/31/1997 | CA2243497A1 Substrates and inhibitors for cysteine protease ich-1 |
| 07/31/1997 | CA2242960A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | CA2242417A1 Novel administration of thrombopoietin |
| 07/31/1997 | CA2242200A1 Toxoplasma gondii antigen tg20 |
| 07/31/1997 | CA2241319A1 Highly concentrated, lyophilized, and liquid factor ix formulations |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786522A2 Enzymatic RNA molecules for treatment of stenotic conditions |
| 07/30/1997 | EP0786520A1 Method for the production of biological active beta-NGF by genetic engineering |
| 07/30/1997 | EP0786474A1 A recombinant buman factor VIII derivative |
| 07/30/1997 | EP0786473A2 Basic protein composition, basic peptide composition and application thereof |
| 07/30/1997 | EP0786472A1 Vaccines and diagnostic assays for Haemophilus influenzae |
| 07/30/1997 | EP0786470A1 Peptide compound |
| 07/30/1997 | EP0786257A1 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 07/30/1997 | EP0786256A2 Obesity protein formulations |
| 07/30/1997 | EP0786255A1 Methods of improving allograft or xenograft tolerance by administration of an LFA-3 or CD2 binding protein |
| 07/30/1997 | EP0786083A1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings |
| 07/30/1997 | EP0786010A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| 07/30/1997 | EP0786005A1 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 07/30/1997 | EP0786004A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 07/30/1997 | EP0786002A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 07/30/1997 | EP0786001A1 Chemokine-like proteins and methods of use |
| 07/30/1997 | EP0786000A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/30/1997 | EP0785998A1 Asymmetric hammerhead ribozymes and nucleotide sequences for their construction |
| 07/30/1997 | EP0785995A1 A novel enzyme with beta-1,3-glucanase activity |
| 07/30/1997 | EP0785990A1 Method for stimulating profileration of colon cells using pomc 76-103 |
| 07/30/1997 | EP0785951A1 Tc or re radiolabelled somatostatin analogs |
| 07/30/1997 | EP0785950A2 Keratinocyte growth factor analogs |
| 07/30/1997 | EP0785948A1 Analogs of keratinocyte growth factor |
| 07/30/1997 | EP0785947A1 Peptides endowed with antiinflammatory activity |
| 07/30/1997 | EP0785945A1 New peptides with immunomodulatory effects |
| 07/30/1997 | EP0785944A1 Acyl amino acetamide derivatives with agonist activity for cck-a receptors |
| 07/30/1997 | EP0785803A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 07/30/1997 | EP0785801A1 Treatment of tissues to reduce subsequent response to injury |
| 07/30/1997 | EP0785799A1 Process for production of inhibited forms of activated blood factors |
| 07/30/1997 | EP0785798A1 Formulations comprising therapeutically-active proteins or polypeptides |
| 07/30/1997 | EP0785797A1 A pharmaceutical formulation comprising a growth hormone and leucine |
| 07/30/1997 | EP0785796A1 A pharmaceutical formulation comprising a growth hormone and isoleucine |
| 07/30/1997 | EP0785795A1 A pharmaceutical formulation comprising a growth hormone and valine |
| 07/30/1997 | EP0785794A1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 07/30/1997 | EP0785793A1 Allosteric modulators of the nmda receptor |